The FTC accuses major PBMs of inflating insulin prices, impacting patient costs and access to affordable medications. PBMs prioritize high-rebate drugs, contributing to high insulin prices and ...

While liberals have held their tongues as Kamala Harris tacked to the center, they're preparing for a major battle over the ...

Ohioans must recognize the threat that vertically-integrated insurance conglomerates pose to our health and pocketbooks.

Last month, the FTC sued the "big three" for artificially inflating insulin prices. The Department of Justice Antitrust Division has launched a task force to examine the harms of vertical ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Pharmacy benefits managers have a tremendous impact on medication coverage. In my last article, which was devoted to the causes of dramatically rising prescription drug costs and potential ...

One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company ...

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.